ClinicalTrials.gg
Not yet recruitingNCT07603206Updated May 22, 2026

Replacing Gas Stoves With Portable Electric Appliances to Improve Indoor Air Quality and Asthma Control

An interventional study of Portable cooking appliances in Asthma Control, sponsored by MetroHealth Medical Center. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by MetroHealth Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goals of this study are to determine if replacing gas stoves with portable electric hot plates and electric toaster ovens will improve indoor air quality and asthma control. Researchers will enroll participants with poorly controlled asthma and provide them with hot plates and toaster ovens to use instead of gas stoves. Researchers will measure indoor air quality about 1-2 weeks before and about 2-3 months after providing portable appliances. Participants will answer questions about their asthma symptoms and take lung function tests about 1-2 weeks before and about 2-3 months after using portable appliances.

Read the detailed description

Cooking on natural gas stoves is a major source of indoor air pollution and may contribute to asthma exacerbations. The investigators recently completed a single-arm trial in which gas stoves were replaced with electric induction stoves in the homes of 85 individuals with poorly controlled asthma. This led to 70% reductions in indoor NO2 levels and clinically important improvements in multiple measures of asthma control. Asthma Control Questionnaire scores improved by 1.1 points in this trial, which is twice as large as the average improvement seen with medical treatment such as inhaled corticosteroids and/or long-acting beta-agonists.

While these results are promising, the trial lacked a control group which limits the causal inferences that can be drawn. In addition, lung function was not directly measured. Moreover, the costs for stove installation and required electrical upgrades averaged nearly $10,000 per home. Most of this cost was related to the older housing stock of trial participants that often required upgrading the entire electrical panel in a house to install a new 240-volt kitchen outlet for the new electric stove. These costs can be a financial challenge for low-income households, limiting the scalability of a potentially effective solution for improving indoor air quality and asthma control.

To address these limitations, the investigators now propose a pilot randomized controlled trial using a delayed crossover design to evaluate the effectiveness of a low-cost intervention to improve indoor air quality, asthma control, and lung function. The investigators will leave gas stoves in place but will instruct participants to preferentially use two relatively inexpensive portable electric appliances that the investigators will provide. Cooking will be done with an electric induction hot plate and baking with an electric toaster oven. Induction hot plates use magnetic coils beneath a ceramic glass surface to send electromagnetic pulses directly to cookware. The investigators will provide induction stove compatible cookware because it is necessary to use cookware that has some steel or iron in order for the energy transfer to work.

The two portable electric appliances and induction cookware are estimated to cost approximately $600 in total and may provide a more affordable option for low-income households. If a household already has a microwave oven, they will be encouraged to use that as well. As the future scalability of the intervention will depend on its usage, the investigators will also evaluate usage and identify facilitators and barriers to consistent use of the portable devices.

02

Conditions studied

  • Asthma Control

Browse trials for

Keywords

  • asthma
  • indoor air quality
03

In context

Asthma

4,841 studies on the registry are indexed under Asthma; 600 are open to participants now.

This study's planned enrollment of 20 is below the median of 78 across 3,341 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

MetroHealth Medical Center is the lead sponsor of 104 studies on the registry; 20 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 7 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Currently use gas stove for cooking or baking at least three times a week
  • Poorly controlled asthma as defined by an Asthma Control Questionnaire score of 1.5 or larger

Exclusion criteria

Exclusion Criteria:

  • Impaired decision making capacity
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Immediate Intervention

    Participants will receive electric hotplate and electric toaster oven immediately after enrollment.

    Other: Portable cooking appliances

  • Experimental
    Delayed Intervention

    Participants will receive electric hotplate and electric toaster oven six months after enrollment.

    Other: Portable cooking appliances

Interventions

  • OtherPortable cooking appliances

    The investigators will leave gas stoves in place but will instruct participants to preferentially use two relatively inexpensive portable electric appliances that the investigators will provide. Cooking will be done with an electric induction hot plate and baking with an electric toaster oven.

06

What researchers measure

Primary outcomes

  1. Change in asthma control

    Change in Asthma Control Questionnaire score from baseline to final assessment. Asthma Control Questionnaire scores can range from 0 to 6 with higher scores indicating poor asthma control.

    Time frame: Baseline assessment 1-2 weeks before portable appliances given to participant. Final assessment 2-3 months after portable appliances given to participant.

  2. Change in indoor nitrogen dioxide levels

    Change in nitrogen dioxide level from baseline to final assessment

    Time frame: Baseline assessment 1-2 weeks before portable appliances given to participant. Final assessment 2-3 months after portable appliances given to participant.

Secondary outcomes

  1. Change in forced expiratory volume in 1 second (FEV1)

    Changes in FEV1 from baseline to final assessment.

    Time frame: Baseline assessment 1-2 weeks before portable appliances given to participant. Final assessment 2-3 months after portable appliances given to participant.

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Bime C, Nguyen J, Wise RA. Measures of asthma control. Curr Opin Pulm Med. 2012 Jan;18(1):48-56. doi: 10.1097/MCP.0b013e32834db0f2. PubMed 22081089 ↗
  • Audignon-Durand S, Ramalho O, Mandin C, Roudil A, Le Bihan O, Delva F, Lacourt A. Indoor exposure to ultrafine particles related to domestic activities: A systematic review and meta-analysis. Sci Total Environ. 2023 Dec 15;904:166947. doi: 10.1016/j.scitotenv.2023.166947. Epub 2023 Sep 9. PubMed 37690752 ↗
  • Lebel ED, Finnegan CJ, Ouyang Z, Jackson RB. Methane and NOx Emissions from Natural Gas Stoves, Cooktops, and Ovens in Residential Homes. Environ Sci Technol. 2022 Feb 15;56(4):2529-2539. doi: 10.1021/acs.est.1c04707. Epub 2022 Jan 27. PubMed 35081712 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for May 2029, 35 months later.

Of 599 non-industry interventional studies with no phase under Asthma, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 50. This study's planned 35 months is above that.

Counting every sponsor, half of 649 studies reached it within 23 months; a quarter within 10 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 28, 2026
First posted
May 22, 2026
StartEst.
Jun 2026
Primary completionEst.
May 2029
CompletionEst.
May 2029
Last update
May 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07603206
Responsible party
Ash Sehgal (Professor, MetroHealth Medical Center) — Principal investigator
First posted
May 22, 2026
Start date
Jun 2026 (estimated)
Primary completion
May 2029 (estimated)
Completion
May 2029 (estimated)
Last update
May 22, 2026

Study contacts

Ash Sehgal, MD
Contact
axs81@cwru.edu
216-778-7728
Ther Aung, PhD
Contact
taung@metrohealth.org
216-778-4061

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion